Clinical Trial Update: Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the effects of 500 mg immediate-release and extended-release methylnaltrexone on loperamide-induced delays in orocecal and who…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Obstruction

Drugs mentioned

• RELISTOR (methylnaltrexone)

Snippet

Sponsor: University Medicine Greifswald | Conditions: Intestinal Obstruction | Phase 1 | Status: COMPLETED